WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: BRIUMVI

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on BRIUMVI

Proof of use for BRIUMVI

We do not have any records of a proof of use for BRIUMVI at this moment.

Click here to add a proof of use for BRIUMVI

Possible trademark infringements of BRIUMVI

Basic Information about BRIUMVI

Serial Number
90760688
Filing Date
08 Jun 2021
Registration Number
7026905
Registration Date
11 Apr 2023
Mark Drawing Code
4

Classifications

Declare the trademark use of BRIUMVI on the blockchain with WikiTrademarks.io.

First use of BRIUMVI anywhere
BRIUMVI was first used on 24 Jan 2023 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
005; 006; 018; 044; 046; 051; 052

Who owns BRIUMVI?

1. TG Therapeutics, Inc. New York NY

2. TG Therapeutics, Inc. New York NY

3. TG Therapeutics, Inc. New York NY

Correspondent

Maury M. Tepper, III
TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH, NC 27609

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on BRIUMVI